PMV Pharmaceuticals Cash Flow Statement (2019-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-12.87M	-15.01M	-18.36M	-18.43M	-17.31M	-18.23M	-19.34M	-19.13M	-17.44M	-16.64M	-15.76M	-15.27M	-1.21M	-19.23M	-23.10M	-17.44M	-21.21M	-21.06M	-18.06M	-18.04M
Depreciation and Depletion (Quarter)	0.07M	0.08M	0.08M	0.08M	0.08M	0.07M	0.07M	0.17M	0.37M	0.36M	0.36M	0.36M	0.37M	0.37M	0.04M	0.04M	0.03M	0.03M	0.03M	0.03M
Share-based Compensation (Quarter)	1.15M	1.80M	1.77M	2.18M	2.52M	2.45M	3.05M	2.93M	3.15M	3.32M	2.97M	2.61M	2.77M	2.22M	1.27M	1.51M	13.87M	1.38M	1.36M	1.39M
Cash from Operations (Quarter)	-9.24M	-12.40M	-12.03M	-18.00M	-13.68M	-16.76M	-15.32M	-15.01M	-12.90M	-15.66M	-12.09M	-16.18M	-1.60M	-16.84M	-16.66M	-18.27M	-18.30M	-19.82M	-17.19M	-19.68M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.17M	-0.13M	-0.09M	-0.05M	-0.07M	0.23M	0.53M	0.71M	0.96M	1.84M	1.88M	1.63M	1.38M	1.24M	1.13M	0.84M	0.72M	0.69M	0.51M	0.39M
Depreciation & Amortization (CF) (Quarter)	0.07M	0.08M	0.08M	0.08M	0.08M	0.07M	0.07M	0.17M	0.37M	0.36M	0.36M	0.36M	0.37M	0.37M	0.04M	0.04M	0.03M	0.03M	0.03M	0.03M
Change in Working Capital
Change in Account Payables (Quarter)	1.12M	-1.15M	0.58M	0.24M	-1.58M	2.21M	-1.26M	-1.52M	2.01M	-1.81M	1.55M	-2.38M	3.68M	-2.47M	4.52M	-2.99M	-0.99M	0.80M	-0.24M	-1.52M
Change in Accured Expenses (Quarter)	0.44M	2.62M	1.71M	-2.06M	1.09M	-1.22M	0.87M	1.23M	-0.59M	1.10M	0.90M	0.38M	-4.62M	4.56M	-2.82M	-1.64M	2.83M	-0.12M	-0.66M	-1.19M
Other Working Capital Changes (Quarter)	-0.38M	1.17M	-1.78M	0.92M	-0.62M	1.89M	-0.37M	-2.11M	-0.65M	0.05M	0.98M	0.17M	1.35M	0.91M	0.25M	-3.09M	-0.08M	0.16M	-0.92M	-0.05M
Investing Activities
Capital Expenditures (Quarter)	0.47M	0.50M	0.26M	0.80M	0.70M	4.84M	-6.15M	0.16M	0.56M	0.04M	-0.76M	0.59M	0.00M	0.00M	0.06M	0.00M	0.01M	-0.00M	0.01M
Sales of Property, Plant and Equipment (Quarter)															0.22M			0.00M
Change in Acquisitions & Divestments (Quarter)		49.75M	29.50M	55.68M	43.74M	76.85M	59.55M	73.30M	42.65M	24.00M	31.00M	57.25M	43.21M	56.49M	45.09M	44.45M	41.93M	32.50M	39.50M	31.50M
Cash from Investing Activities (Quarter)	-10.55M	-0.69M	7.56M	-38.83M	-15.28M	29.51M	23.22M	49.65M	-63.96M	-33.64M	-2.59M	26.17M	2.32M	17.12M	7.74M	28.71M	10.99M	12.03M	18.44M	20.82M
Financing Activities
Other financing activities (Quarter)	1.26M	0.31M	0.29M	0.13M	0.28M	0.01M	0.55M	0.01M	0.10M	0.05M	0.29M		0.14M		0.17M	0.01M	0.10M		0.39M
Cash from Financing Activities (Quarter)	1.26M	0.31M	0.29M	0.13M	0.28M	0.01M	0.55M	0.01M	2.13M	33.15M	0.29M		0.14M		0.17M	0.01M	0.10M		0.39M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)										33.10M
Additional items
Exchange Rate Effect (Quarter)												-0.03M	0.01M	0.00M	-0.01M	0.01M	-0.00M	0.00M	-0.00M	0.00M
Change in Cash (Quarter)	-18.54M	-12.78M	-4.17M	-56.70M	-28.68M	12.76M	8.45M	34.65M	-74.73M	-16.15M	-14.35M	9.95M	0.87M	0.28M	-8.76M	10.46M	-7.21M	-7.79M	1.65M	1.15M
Free Cash Flow (Quarter)	-9.71M	-12.90M	-12.29M	-18.79M	-14.38M	-21.60M	-9.17M	-15.17M	-13.47M	-15.70M	-11.33M	-16.78M	-1.60M	-16.84M	-16.72M	-18.27M	-18.31M	-19.82M	-17.20M	-19.68M
Net Cash Flow (Quarter)	-18.54M	-12.78M	-4.17M	-56.70M	-28.68M	12.76M	8.45M	34.65M	-74.73M	-16.15M	-14.38M	9.98M	0.87M	0.28M	-8.74M	10.46M	-7.21M	-7.79M	1.65M	1.15M

Research Tools

Datasets

Plans

Developers

PMV Pharmaceuticals PMVP Cash Flow Statement (2019-2026)

Research Tools

Datasets

Plans

Developers

PMV Pharmaceuticals PMVP Cash Flow Statement (2019-2026)

Create an account

Sign In

Reset Password